Literature DB >> 10506944

Intraocular neovascularization.

A Yoshida1, S Yoshida, T Ishibashi, H Inomata.   

Abstract

An important character of the eye is transparency, so intraocular neovascularization, which is fragile and likely to result in hemorrhage, would cause a functional disorder of the eye and contribute to loss of vision associated with such diseases as retinopathy of prematurity, diabetic retinopathy, retinal vein occlusion, and age-related macular degeneration. Recently interest in the mechanisms of intraocular neovascularization has increased, and the mechanisms have been gradually elucidated using several in vitro and in vivo angiogenesis models. Blood vessels in the eye are composed of, and surrounded by, various types of cells that produce multiple factors. Neovascularization is regulated by complex interactions among these angiogenic factors, angiostatic factors, and adhesion molecules, and some of these angiogenesis-related molecules have also been suggested as new targets for novel therapeutic agents of intraocular neo-vascularization. This review focuses on in vivo representative angiogenesis models of the corneal pocket model and the model of oxygen-induced retinopathy, and discusses the role of some angiogenesis-related factors and adhesion molecules in intraocular neovascularization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506944     DOI: 10.14670/HH-14.1287

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  9 in total

Review 1.  Periostin in vitreoretinal diseases.

Authors:  Shigeo Yoshida; Takahito Nakama; Keijiro Ishikawa; Shintaro Nakao; Koh-Hei Sonoda; Tatsuro Ishibashi
Journal:  Cell Mol Life Sci       Date:  2017-09-14       Impact factor: 9.261

Review 2.  Diverse roles of macrophages in intraocular neovascular diseases: a review.

Authors:  Ye-Di Zhou; Shigeo Yoshida; Ying-Qian Peng; Yoshiyuki Kobayashi; Lu-Si Zhang; Luo-Sheng Tang
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

3.  Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation.

Authors:  Shigeo Yoshida; Ayako Yoshida; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-03-17       Impact factor: 3.117

Review 4.  Roles of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase in Angiogenesis: Isoform-Specific Effects.

Authors:  Haibo Wang; M Elizabeth Hartnett
Journal:  Antioxidants (Basel)       Date:  2017-06-03

5.  Identifying circRNA-associated-ceRNA networks in retinal neovascularization in mice.

Authors:  Manjing Cao; Lusi Zhang; Jiang-Hui Wang; Huilan Zeng; Yingqian Peng; Jingling Zou; Jingming Shi; Liwei Zhang; Yun Li; Shigeo Yoshida; Luosheng Tang; Yedi Zhou
Journal:  Int J Med Sci       Date:  2019-09-20       Impact factor: 3.738

6.  Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development.

Authors:  Dru S Dace; Aslam A Khan; Jennifer Kelly; Rajendra S Apte
Journal:  PLoS One       Date:  2008-10-13       Impact factor: 3.240

7.  Interleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy.

Authors:  Yedi Zhou; Shigeo Yoshida; Yuki Kubo; Yoshiyuki Kobayashi; Takahito Nakama; Muneo Yamaguchi; Keijiro Ishikawa; Shintaro Nakao; Yasuhiro Ikeda; Tatsuro Ishibashi; Koh-Hei Sonoda
Journal:  Sci Rep       Date:  2016-06-17       Impact factor: 4.379

8.  Relationship between Pericytes and Endothelial Cells in Retinal Neovascularization: A Histological and Immunofluorescent Study of Retinal Angiogenesis.

Authors:  Se Hyun Choi; Minhwan Chung; Sung Wook Park; Noo Li Jeon; Jeong Hun Kim; Young Suk Yu
Journal:  Korean J Ophthalmol       Date:  2018-01-25

Review 9.  Involvement of lncRNAs and Macrophages: Potential Regulatory Link to Angiogenesis.

Authors:  Yang Jia; Yedi Zhou
Journal:  J Immunol Res       Date:  2020-02-29       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.